BDKRB1 Antikörper

Produktnummer ABIN6290094

Produktdetails anti-BDKRB1 Antikörper

Target: BDKRB1 (Bradykinin Receptor B1 (BDKRB1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BDKRB1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Affinity purification

Immunogen: A synthetic peptide of human BDKRB1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol,  pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20C. Avoid freeze / thaw cycles.

Details zu BDKRB1

Target: BDKRB1 (Bradykinin Receptor B1 (BDKRB1))

Andere Bezeichnung: BDKRB1 (BDKRB1 Produkte)

Synonyme: bdkrb2 antikoerper, LOC100230525 antikoerper, B1BKR antikoerper, B1R antikoerper, BKB1R antikoerper, BKR1 antikoerper, BRADYB1 antikoerper, BKR antikoerper, Bdkrb antikoerper, b1bkr antikoerper, bradykinin receptor B1 antikoerper, bradykinin receptor, beta 1 antikoerper, bdkrb1 antikoerper, BDKRB1 antikoerper, Bdkrb1 antikoerper

Hintergrund: Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Several transcript variants encoding different isoforms have been found for this gene.

Molekulargewicht: 40.495 kDa

Gen-ID: 623

UniProt: P46663

Pathways: ACE Inhibitor Pathway